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T 
UMOR necrosis factor c~ (TNF) ~ and tumor necrosis 
factor ~  (lymphotoxin)  are two cytokines produced 
primarily by macrophages and lymphocytes, respec- 
tively. These cytokines are recognized by the same cell sur- 
face receptors and are associated with similar biological ac- 
tivities.  Some of the well-known TNF effects include septic 
shock, cytotoxicity, inflammation,  and cachexia. The role of 
TNF in the pathology of these disease states has been in- 
ferred from studies of: (a) the effects of TNF administration 
in both patients  and animal  models; (b) the effects of neu- 
tralizing  anti-TNF  antibody,  (Fiers,  1991; Vassalli,  1992); 
and (c) the phenotype of mice made deficient for the 55-kD 
TNF receptor by gene targeting  (Pfeffer et al.,  1993; Rothe 
et al.,  1993). 
Of these major responses associated with TNF, the septic 
shock syndrome results  from the reaction of the body to 
parasitic,  bacterial or viral infections.  Following  endo- or 
exotoxic challenge,  TNF is produced by macrophages and is 
believed  to  augment  their  production  and  their  phago- 
cytic/cytotoxic actions.  The effects of septic shock can be 
mimicked by higher doses of TNF and these effects can be 
prevented  by the prior injection  of anti-TNF antibody (Vas- 
salli,  1992).  Direct cytotoxicity has  been a  widely cited 
effect to account for the harmful effects of TNE  However, 
TNF kills most cells only in the presence of metabolic inhib- 
itors like actinomycin  D  and cycloheximide  (CHX), con- 
ditions that are nonphysiological.  Notwithstanding,  the phe- 
nomenon  of TNF-induced cell killing  has  attracted  great 
attention and cells that are killed by TNF alone have become 
popular model systems for TNF cytotoxicity (see Heller et 
al.,  1992). Inflammation  as a general consequence of TNF 
action is likely to be related to TNF stimulation  of arachi- 
donic acid (AA) release,  activation  of cytosolic phospholi- 
pase A2 (cPLA2) and production of pro-inflammatory medi- 
ators  like prostaglandins  and leukotrienes.  TNF's role in 
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osteo and rheumatoid arthritis  may also be explained by the 
induction  of matrix degrading  proteins like interstitial  col- 
lagenase  and  stromelysin  (Fiers,  1992  and  see  below). 
Lastly,  cachexia  is  a  wasting  syndrome  associated  with 
chronic diseases such as cancer and tuberculosis and results 
in weight loss, loss of muscle and fat, and an inability to de- 
velop these tissues. At the cellular level, lipid mobilizing en- 
zymes such as  lipoprotein-lipase  prevent  the uptake and 
storage  of fat,  while  the  expression  of muscle-  and  fat- 
specific genes is suppressed (Tracey and Cerami,  1993). 
TNF triggers the synthesis and secretion of most if not all 
proinflammatory mediators including IL-I, other cytokines, 
and lipid mediators like platelet-activating  factor, to amplify 
its range  of actions.  Any picture of TNF biology deduced 
from its direct action on cells, inevitably is an underestimate 
of its pathophysiological  role in host defense reactions and 
disease.  A comprehensive account of the cellular responses 
to TNF and its protective role in various disease states such 
as autoimmune disease,  cancer,  bacterial, viral, and para- 
sitic infections is presented in recent reviews (Vassalli, 1992; 
Tracey  and Cerami,  1993). 
TNF binds to two cell surface receptors, one is ,,o55 kD 
(p55 TNFR), and the other is 70-80 kD in size (p75 TNFR). 
The receptors are glycoproteins with a  single  membrane- 
spanning  hydrophobic  segment,  and they are expressed on 
the  surface of most cells,  although  in different  amounts. 
Based mostly on similarities  in their extracellular  domains 
these receptors belong to a receptor superfamily which in- 
cludes the low-affinity nerve growth factor receptor and the 
Fas-antigen  or APO-1 (Nagata,  1993; Smith et al.,  1994). 
Most of the known TNF responses occur by the activation 
of the p55 TNFR (Wiegmann  et al.,  1992) and this notion 
has been confirmed in vivo. Mice deficient for the p55 TNFR 
were  resistant  to  lipopolysaccharide  or  Staphylococcus 
aureus enterotoxic shock yet proved compromised in their 
ability to clear intracellular  bacteria like Listeria monocyto- 
genes (Pfeffer et al., 1993; Rothe et al., 1993). However, thy- 
mocyte proliferation  is associated with p75-TNFR (Tartaglia 
et al., 1991) and cytotoxicity may be a function ofp75-TNFR 
acting alone or together with the p55-TNFR (Heller et al., 
1992; Grell et al.,  1993).  Several  review articles on TNF 
receptor structure and TNF responses have been published 
recently (Vilcek and l~.e,  1991; Fiers,  1991; Tartaglia  and 
Goeddel, 1992; Rothe et al., 1992), this article will therefore 
focus on the signaling pathways activated by these receptors 
and how they might interact to produce the diverse actions 
of TNE 
© The Rockefeller University Press, 0021-9525/94/07/5/5 $2.00 
The Journal of Cell Biology, Volume 126, Number 1, July 1994 5-9  5 A  comparison of the intracellular sequences of the two 
TNFRs  shows  no  obvious  sequence  similarity to  known 
tyrosine- or  serine/threonine kinase encoding  sequences. 
Both receptors are rich in serine and theonine residues which 
may serve as sites of phosphorylation by other cellular ki- 
nases.  The p55  TNFR also contains a tyrosine residue, a 
possible phosphorylation site for a heterologous tyrosine ki- 
nase. In the absence of any obvious catalytic function, one 
approach has been to screen for intermediates involved in 
signaling pathways of other cell surface receptors. Another 
approach is to use pharmacological agents to dissect TNF 
responses.  The rapid induction by TNF of early response 
genes such as c-fos and c-jun or the activation of transcrip- 
tion factor like nuclear factor-kB (NFkB) have been used 
to  monitor its  intraceUular signaling intermediates.  Such 
efforts have  identified several  phospholipases,  such  as  a 
phosphatidylcholine-specific  phospholipase  C  (PC-PLC) 
and sphingomyelinases, both of which produce recognized 
second  messenger  molecules  like  DAG  and  ceramides, 
respectively. Central to the proinflammatory  actions of  TNF, 
might be the activation of cytoplasmic phospholipase A2, 
that generates arachidonic acid which in turn can be metabo- 
lized to leukotrienes and prostaglandins (Fig.  1). 
TNF Causes a Rapid Increase of 
Diacylglycerol  via Hydrolysis of  Phosphatidylcholine 
by Phospholipase C 
Within minutes after binding to the p55 TNFR, TNF stimu- 
lates the production of diacylglycerol  from membrane phos- 
pholipids by activation of a PLC. Under these conditions, di- 
acylglycerol  (DAG) production is accompanied by a lowering 
Figure  1.  Tumor necrosis factor  receptor  signaling. Proposed 
model for some of  the pathways  mediating  TNF action from the cell 
surface to the nucleus. TR, TNFR; 1RE, TPA responsive element; 
other abbreviations are defined in the text. 
of cellular PC levels and increased phosphorylcholine con- 
tent without changes in phospholipase D activity, phospha- 
tidic acid phosphohydrolases, cellular Ca  2+ or inositol tris- 
phosphate content.  Such observations indicate a  PC-PLC 
action  (Schutze et al.,  1991). PC  hydrolysis by PC-PLC 
results in DAG generation without a concomitant increase in 
intracellular Ca  2+ levels.  The DAG generated by PC-PLC 
appears central to the activation of at least two other signal- 
ing enzymes, protein kinase C  (PKC),  and acidic sphin- 
gomyelinase (SMase). Since Ca  2+ mobilization is not an ac- 
companying feature, the DAG responsive PKC most likely 
belongs  to  a  Ca2÷-independent  PKC  isotype.  However,  a 
particular PKC isozyme activated by TNF  remains to be 
identified particularly since PKC does mediate a number of 
TNF actions, most notably, the induction of JUN and FOS 
proteins that are components of the AP-1 transcription factor 
(Brenner et al.,  1989). 
DAG Generated by a PC-PLC Activates an 
Acidic SMase 
The DAG generated by the TNF-responsive PC-PLC leads 
to the activation of a C type phospholipase, the acidic SMase 
(Schutze et al., 1992).  Of the two types of SMases found in 
cells, one, the acidic SMase, has a pH optimum in the acid 
range •pH  5.0 and the other, the neutral SMase, ~pH 7.0. 
Diacylglycerols  are known activators of  protein kinase C, but 
by stimulating the activity of an acid SMase they cause a 
breakdown of sphingomyelin to  producer  ceramides.  Al- 
though the phorbol esters,  12-o-tetradecanoyl phorbol  13- 
acetate (TPA),  and phorbol 12,13-dibutyrate activate PKC, 
they do  not  alter  SMase  activity.  The  action  of diacyl- 
glycerols on  SMase  is  reported  to be  independent of its 
effects on PKC. In cells where PKC action is down regulated 
with phorbol esters, DAG can still increase SMase activity 
(Kolesnick, 1987). 
The products of SMase hydrolysis of sphingomyelin are 
phosphorylcholine and ceramide. The latter acts as the sec- 
ond messenger mediating a  number of cellular responses 
(Hannum,  1994).  Activation by DAG of an acidic SMase, 
which presumably resides in acidic cellular compartments 
like lysosomes and endosomes, may occur via co-internal- 
ization of DAG with TNF/TNFR complexes, if PC-PLC ac- 
tion occurs in close vicinity to membrane receptors.  En- 
dosomal vesicles are rapidly acidified and provide optimal 
conditions for acidic SMase activity. Clearly, the significance 
of TNFR internalization for acidic SMase action needs fur- 
ther investigation. 
TNF  Activates a Membrane-bound 
Neutral Sphingomyelinase 
A  neutral SMase has been demonstrated to play a role in 
TNF signaling (Kim et al., 1991). This TNF responsive neu- 
tral  SMase hydrolyses membrane  sphingomyelin to  cera- 
mide  which  activates  a  membrane-bound  97-kD  kinase 
termed the ceramide-activated protein kinase (Liu et al., 
1994).  This enzyme phosphorylates peptide substrates con- 
taining the motif X-Ser/Thr-Pro-X, found in the EGFR and 
myelin basic protein (MBP), a motif that is a consensus se- 
quence for the action of mitogen-activated  protein (MAP) ki- 
nases (or extracellular signal-regulated kinases). The 97-kD 
kinase appears  to  be  a  member  of this  class  of proline- 
The Journal  of Cell Biology,  Volume 126, 1994  6 directed kinases but distinct from them in its membrane as- 
sociation and slightly different substrate preference.  TNF 
reportedly also activates the 42- and 44-kD MAP kinases 
and increases their tyrosine phosphorylation as well as their 
ability to phosphorylate the standard substrate MBP (Vietor 
et al., 1993).  The phosphorylation and activation of the 42- 
kD MAP kinase by TNF parallels an increase in cellular 
sphingomyelin hydrolysis and the addition of both bacterial 
SMase or cell-permeable ceramide analogs activate the p42 
MAP kinase in a time-dependent manner, similar to TNF 
(Raines et al., 1993). Therefore, both the ceramide-activated 
kinase and the MAP kinases are activated by TNF and cera- 
mides. 
The distinction between acidic and neutral SMase seems 
both noteworthy and indisputable. These two C type phos- 
pholipases could exert functions, quite distinct, by virtue of 
their  different compartments  of localization.  Due  to  its 
hydrophobicity, ceramide is not readily distributed within 
the cell so that ceramide signaling is likely to be confined 
to its site of production in the membrane. While ceramide 
produced by neutral SMase at or within the plasma mem- 
brane seems to trigger a plasma membrane-associated ki- 
nase (Liu et al.,  1994),  ceramide produced by the acidic 
SMase is associated with the endolysosomal compartments 
and therefore may have different consequences. 
TNF Increases Phospholipase Az Activity 
AA release by TNF occurs in number of cell lines. Indeed, 
TNF mediates increases in both the secreted 14 kD (Oka and 
Arita, 1991) and the cellular 85-kD phospholipases (Hoeck 
et al., 1993),  enzymes known for the production of AA by 
cells.  Although the  14-kD  sPLA: may not be specific for 
release of AA from the sn-2 position of membrane phospho- 
lipids,  the  85-kD  cPLA2  is  selective for AA (Lin et al., 
1992) and provides a source for the production of biologi- 
cally active lipid mediators such as prostaglandins and leu- 
kotrienes. This action could account for the proinflamma- 
tory properties of TNE An earlier action of TNF on cPLA2 
is a phosphorylation of the enzyme, followed by a sustained 
production of new protein. TNF-induced phosphorylation of 
cPLA~ causes a small increase in activity, but with Ca  2+ it 
produces a marked stimulation. In combination with Ca  2+ 
mobilizing agonists at sites of  inflammation, the released AA 
could serve both a regulatory function and have a proinflam- 
matory action. The effect of the antiinflammatory glucocor- 
ticoid dexamethasone is likely to be due to its inhibition of 
TNF-induced cPLA~ production because it does not affect 
cPLA2 activation by phosphorylation. 
TNF-triggered release of AA provides a  source for the 
production of eicosanoids. Although the pathway from the 
TNF receptor to cPLA2 activation is not completely clear, 
the SMase/ceramide cycle possibly offers a link. cPLA2 is 
phosphorylated on serine residues by protein kinase C and 
the p42 MAP kinase, and the MAP-kinase mediated phos- 
phorylation is essential for receptor-induced cPLA2 activa- 
tion (Lin et al., 1993; Nemenhoff et al., 1993). Growth fac- 
tors  have  been  reported  to  induce  MAP  kinase  activity 
through a cascade of signal transfer reactions including ras 
and raf proteins, and the serine/threonine MAP kinase ki- 
nases,  which  regulate  the  activity  of  the  MAP  kinase 
(reviewed by Thomas, 1992). Since the TNF/SMase initiated 
protein phosphorylation cascade stimulates a MAP kinase 
pathway and the p42  MAP kinases activate cPLAe,  it is 
conceivable that the ceramide-activated protein kinase is an 
intermediate in the MAP kinase action pathway, particularly 
if  c-Raf  could serve as a substrate for ceramide activated pro- 
tein kinase (Liu et al.,  1994). 
The Cytotoxic Action of TNF and its 
Signaling Intermediates 
One of the prominent features of  TNF is its ability to kill sev- 
eral cell lines. The loss of viability upon TNF treatment of 
certain cells is accompanied by sphingomyelin hydrolysis 
and ceramide production. In these cells both TNF and cera- 
mides cause DNA fragmentation by a process identified as 
apoptosis. Thus, it appears that ceramides perhaps through 
their activation of kinases, phosphatases, inhibition of pro- 
tein secretion or as yet unidentified processes could mediate 
the cytotoxic actions of TNF (Jarvis et al.,  1994;  Hannun, 
1994).  Apoptotic  cell  death  is  also  caused  by  the  Fas- 
antigen, a receptor structurally homologous to the TNFRs 
and is triggered by the Fas-ligand, a transmembrane protein 
structurally similar to TNE  Furthermore, the Fas-antigen 
and the p55 TNFR have a 24% sequence identity in a region 
of their cytoplasmic domains that is essential for cell death 
(Nagata, 1993). Whether these two related receptors use the 
ceramide cascade for signaling cell death remains an intrigu- 
ing possibility. As discussed above, the ceramide cascade via 
its activation of MAP kinases is a reasonable pathway for 
TNF activation of the AA selective cPLA2, cPLA2 has also 
been invoked in TNF cytotoxicity. Cells resistant to TNF cy- 
totoxicity have lower levels of this enzyme while introduc- 
tion of this activity into enzyme-deficient  cells restores their 
sensitivity (Hayakawa  et al.,  1993).  One mechanism for 
TNF cytotoxicity by cPLA~ may be the generation of free 
radicals and lipid peroxides via the production of eicosa- 
noids and their metabolites. 
Activation of the Transcription Factor NFkB 
NFkB activation is a cellular response that links cell surface 
receptor activation to transcriptional events in the nucleus. 
Activation of NFkB involves the release of the inhibitory 
subunit IkB  from a  cytoplasmic complex containing the 
DNA-binding subunits p50 and Rel-A (formerly p65). This 
p50/Rel-A heterodimer is then translocated to the nucleus, 
where it directly binds to its DNA recognition sequence. 
Exogenous PC-PLC or synthetic DAGs induce NFkB in 
both intact and in pcrmeabilized Jurkat cells. It is tempting 
to  speculate  that  DAG-mediated NFkB  induction occurs 
through activation of PKC, but this mechanism has never 
been shown to occur in intact cells. Rather, in this case a 
DAG-responsive acidic SMase seems to mediate TNF acti- 
vation of NF-kB since addition of exogenous SMase or cera- 
mide could mimic this effect (Schutze et al.,  1992).  Cera- 
mide production also occurs by a direct activation of neutral 
SMase without an involvement of  PC-PLC and DAG produc- 
tion and ceramide generated by neutral SMase at the mem- 
brane has also been reported to activate NF-kB (Yang et al., 
1993). TNF activation of NF-kB in at least BALB/c 3T3 cells 
has been shown to depend upon Ras and Raf  activities (Finco 
and Baldwin,  1993)  and if indeed, ceramides activate Raf 
proteins, this pathway could explain their activation of NF- 
kB. The differences in the type and mode of SMase activation 
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studies  indicate  that rapid proteolytic degradation  of IkB-a 
by a chymotrypsin-like protease (Henkel et al., 1993) is in- 
duced by TNF (Sun et al.,  1993; Brown et al.,  1993) and 
recently, IkB degradation  was induced by exogenous SMase 
or ceramide in a cell-free system (Macldeidt et al.,  1994). 
Thus,  ceramide  may  induce  phosphorylation  or  another 
modification of the IkB protein, to make the inhibitor more 
susceptible to degradation  by a constitutive  protease or, al- 
ternatively ceramide may activate a protease that selectively 
degrades IkB. 
AA Metabolites Mediate TNF Induction of  c-fos, As 
Well As Cell Killing in the Presence of  CHX 
A role of AA in TNF cytotoxicity is indicated  by experi- 
ments on murine TA1 ceils. In these cells, TNF alone stimu- 
lates the release of AA and causes cell death when combined 
with CHX. A variant of these cells, TA1-R6, is resistant to 
TNF plus CHX killing and has reduced levels of AA in its 
phospholipid pools due to a defect in A6-desammse, an enzyme 
of the AA biosynthetic pathway. Cytotoxicity is restored in 
the TA1-R6 cells by AA supplementation  (Reid et al., 1991). 
Other roles of AA and its metabolites in TNF-mediated re- 
sponses relate to the induction  of c-jun and c-fos mRNA. 
Their protein products are components of  the AP-1 transcrip- 
tion factor complex and specific AP-1 recognition  sequence 
motifs are found in many TNF inducible genes, e.g., the ma- 
trix metalloproteinases,  collagenase  (Brenner  et al., 1989), 
and stromelysin  (Lee et al.,  1990).  In TA1 cells,  TNF in- 
creases AA release and induces both c-fos and c-jun (Haliday 
et al., 1991). The addition of only AA or its hydroperoxides 
can also induce c-fos but not c-jun.  AA is metabolized by 
both the lipoxygenase  (LO) and cyclooxygenase (CO; pros- 
taglandin  endoperoxide synthase) enzyme systems and even 
though  TNF induces the expression of CO (Jones et al., 
1993) the induction of c-fos by TNF was blocked only by LO 
inhibitors.  Nordihydroguiaretic  acid (NDGA) an inhibitor of 
5-, 12-, and 15-LO, MK886 (a 5-1ipoxygenase inhibitor),  or 
BW755C (an inhibitor of both LO and CO activities)  were 
all  effective. Participation  of the lipoxygenase  products of 
AA has also been noted in TNF plus CHX killing because 
this cytotoxic action on TA1, HeLa and NIH-3T3 cells could 
be blocked by NDGA, MK886,  and also by cinnamyl,3,4- 
dihydroxy-a-cyano-cinnamate  (CDC) an inhibitor of all three 
5-, 12-, and 15-1ipoxygenases (Chang et al., 1992). Because 
some of these inhibitors  have well-known antioxidant  activ- 
ity, the possibility remains that their ability to block eicosa- 
noid biosynthesis may be less relevant than their antioxidant 
action in preventing  these TNF-induced responses. 
The Lipoxygenase  Pathway 
The metabolites of 5-,  12- and 15-lipoxygenase action have 
a wide spectrum of potent biological actions (Samuelsson et 
al., 1987). Their production by oxidation reactions of arachi- 
donic  acid  generates  compounds  like  hydroperoxy-,  and 
hydroxy-eicosatetraenoic  acids, dihydroxy-, epoxy-eicosatri- 
enoic acids,  and leukotrienes (I-IPETES, HETES, DHET, 
EET,  and LT). Lipoxygenase metabolites have been impli- 
cated in TNF responses such as TNF cytotoxicity, induction 
of the transcription  factor c-fos, and the mitochondrial su- 
peroxide radical scavenging enzyme manganous  superoxide 
dismutase or MnSOD (Haliday et al.,  1991; Chang  et al., 
1992). TNF treatment of TA1 cells increases the level of the 
leukotriene 5-HETE and supplementation  of hydroperoxy- 
llpoxygenase  products,  5-,  12-, and  15-HPETES,  causes 
c-los  induction.  In  contrast,  the  leukotriene  metabolites 
LTB4, LTC4, LTD4, or HETES do not produce any increase 
in c-fos expression (Haliday et al., 1991), indicating specific 
functions  of particular intermediates. 
The HPETES can be converted into llpoxins  and other 
metabolites  and  these  lipid  peroxidation  products  are  a 
source of reactive-free  radicals  (Samuelsson  et al.,  1987). 
Oxygen radical generation by TNF (Meier et al., 1989; Zim- 
merman et al., 1989) may provide the essential cofactors for 
the induction  of c-los,  MnSOD,  and TNF-cytotoxicity (Ya- 
mauchi  et al.,  1989).  Thiols and reactive  oxygen species 
can induce the transcription  factor NF-kB, and TNF induc- 
tion of NF-kB is blocked by radical  scavenging thiol agents 
(Schreck et al., 1991). TNF cytotoxicity can also be signifi- 
cantly reduced by radical  scavenging thiol agents  such as, 
N-acetyl-L-cysteine and pyrrolldine-dithiocarhamate  to pro- 
vide support for the idea that free radicals may be responsible 
for cell death (Chang et al.,  1992). TNF actions caused by 
free radical production may occur via lipoxygenase metabo- 
rites but the precise pathways for the free radical generation 
and their transfer  to mediate the diverse functions  of TNF 
are currently not clear. 
In summary, there is increasing evidence that TNF signal- 
ing operates via the activation of a SMase-mediated pathway 
through the generation  of ceramides as second messengers. 
This pathway stimulates  MAP-kinase-related serine/threo- 
nine kinases to cause the activation of cPLA2. On the other 
hand,  TNF also activates a PC-PLC to generate DAG in the 
absence of Ca  2+.  PC-PLC-derived DAG can stimulate  an 
endosomal acidic SMase that plays a major role in the activa- 
tion of NFkB. In addition,  DAG also mediates activation of 
a TNF-responsive PKC that likely triggers the activation of 
protooncogenes like c-myc, c-jun, and c-fos. An alternative 
pathway of c-fos induction  involves AA metabolites gener- 
ated by the combined actions of cPLA2 and lipoxygenase. 
The active components of this pathway may be reactive oxy- 
gen or hydroxyl radicals  eventually  responsible for at least 
the induction  of c-fos, MnSOD, and perhaps the cytotoxic 
effects of TNF. The proinfiammatory action of TNF can be 
further explained by the induction of cPLA2, lipoxygenases, 
and prostaglandin  endoperoxide synthase, that generate leu- 
kotrienes  and  prostaglandins.  Moreover,  c-fos  and  c-jun 
induce matrix metalloproteinases  that are involved in inflam- 
matory disease such as arthritis where TNF is a major medi- 
ator (Keffer et al.,  1991). 
Over the past five years, some of the participants  in TNF 
signaling have been identified,  but much work is needed to 
define their interactions.  One major open question in TNF 
action is the role of the p75 TNFR. Apparently, p55 and p75 
TNFR both have unique functions  in cell proliferation  and 
cytotoxicity (Tartaglia  et al.,  1991; Heller et  al.,  1992; 
Ikegami  et al.,  1993;  Grell et al.,  1993).  TNF exhibits  a 
wide variety of functions and the pathways mediating the ac- 
tions of the two TNF receptors may turn out to be equally 
diverse. 
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